Comparable studies of immunostimulating activities in vitro among Mycobacterium bovis bacillus Calmette-Guérin (BCG) substrains

FEMS Immunology and Medical Microbiology

Volumn 56, Issue 2, 2009, Pages 116-128

  Hayashi, Daisuke ^a   Takii, Takemasa ^a   Fujiwara, Nagatoshi ^b   Fujita, Yukiko ^c   Yano, Ikuya ^c   Yamamoto, Saburo ^c,d,e   Kondo, Maki ^a   Yasuda, Emi ^a   Inagaki, Emi ^a   Kanai, Keita ^a   Fujiwara, Akiko ^a   Kawarazaki, Aya ^a   Chiba, Taku ^a,f   Onozaki, Kikuo ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Kiyose   (Japan)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^e TEXAS A AND M UNIVERSITY SYSTEM   (United States)

^f KINJO GAKUIN UNIVERSITY   (Japan)

Author keywords

Bacillus Calmette Gu rin; Cytokine; Trehalose 6,6 dimycolate; Tuberculosis

Indexed keywords

BCG VACCINE; CORD FACTOR; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; AUSTRALIA; BACTERIAL GENOME; BACTERIAL STRAIN; BONE MARROW CELL; CELL WALL; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME INDUCTION; EPITHELIUM CELL; FEMALE; GENE DELETION; GENE INSERTION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INTERFERON INDUCTION; JAPAN; MEXICO; MONOCYTE; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PASTEURELLA; PRIORITY JOURNAL; RUSSIAN FEDERATION; SWEDEN; VIRUS CULTURE;

ANIMALS; CELL LINE; CELLS, CULTURED; CORD FACTORS; EPITHELIAL CELLS; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKINS; MICE; MONOCYTES; MYCOBACTERIUM BOVIS; NITRIC OXIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67650730280     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2009.00559.x     Document Type: Article

References (40)

1. Andersen P Doherty PM (2005) The success and failure of BCG - implications for a novel tuberculosis vaccine. Nat Rev Microbiol 3 : 656 662. (Pubitemid 41052152)
2. Arias M, Zabaleta J, Rodríguez JI, Rojas M, París SC García LF (1997) Failure to induce nitric oxide production by human monocyte-derived macrophages. Manipulation of biochemical pathways. Allergol Immunopath 25 : 280 288. (Pubitemid 128523420)
3. Azuma I Seya T (2001) Development of immunoadjuvants for immunotherapy of cancer. Int Immunopharmacol 1 : 1249 1259. (Pubitemid 32522979)
4. Barry CE III., Lee RE, Mdluli K, Sampson AE, Schroeder BG, Slayden RA Yuan Y (1998) Mycolic acids: structure, biosynthesis and physiological functions. Prog Lipid Res 37 : 143 179. (Pubitemid 28391410)
5. Behr MA, Wilson MA, Gill WP, Salamon H, Schoolnik GK, Rane S Small PM (1999) Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284 : 1520 1523.
6. Behr MA, Schroeder BG, Brinkman JN, Slayden RA Barry CE III. (2000) A point mutation in the mma3 gene is responsible for impaired methoxymycolic acid production in Mycobacterium bovis BCG strains obtained after 1927. J Bacteriol 182 : 3394 3399. (Pubitemid 30341600)
7. Bekierkunst A (1968) Acute granulomatous response produced in mice by trehalose-6,6-dimycolate. J Bacteriol 96 : 958 961.
8. Bekierkunst A, Levij IS, Yarkoni E, Vilkas E Lederer E (1971) Cellular reaction in the footpad and draining lymph nodes of mice induced by mycobacterial fractions and BCG bacilli. Infect Immun 4 : 245 255.
9. Belley A, Alexander D, Di Pietrantonio T, Girard M, Jones J, Schurr E, Liu J, Sherman DR Behr MA (2004) Impact of methoxymycolic acid production by Mycobacterium bovis BCG vaccines. Infect Immun 72 : 2803 2809. (Pubitemid 38542408)
10. Brosch R, Gordon SV, Garnier T et al 2007) Genome plasticity of BCG and impact on vaccine efficacy. P Natl Acad Sci USA 104 : 5596 5601. (Pubitemid 47175726)
11. Chan ED, Chan J Schluger NW (2001) What is the role of nitric oxide in murine and human host defense against tuberculosis? Current knowledge. Am J Resp Cell Mol 25 : 606 612. (Pubitemid 33087112)
12. Dao DN, Sweeney K, Hsu T, Gurcha SS, Nascimento IP, Roshevsky D, Besra GS, Chan J, Porcelli SA Jacobs WR (2008) Mycolic acid modification by the mmaA4 gene of M. tuberculosis modulates IL-12 production. PLoS Pathog 4 : e1000081.
13. Davids V, Hanekom WA, Mansoor N et al 2006) The effect of bacille Calmette-Guérin vaccine strain and route of administration on induced immune responses in vaccinated infants. J Infect Dis 193 : 531 536. (Pubitemid 43202744)
14. Friedland JS, Shattock RJ, Johnson JD, Remick DG, Holliman RE Griffin GE (1993) Differential cytokine gene expression and secretion after phagocytosis by a human monocytic cell line of Toxoplasma gondii compared with Mycobacterium tuberculosis. Clin Exp Immunol 91 : 282 286. (Pubitemid 23045675)
15. Fujita Y, Naka T, Doi T Yano I (2005a) Direct molecular mass determination of trehalose monomycolate from 11 species of mycobacteria by MALDI-TOF mass spectrometry. Microbiology 151 : 1443 1452. (Pubitemid 40711791)
16. Fujita Y, Naka T, McNeil MR Yano I (2005b) Intact molecular characterization of cord factor (trehalose 6,6′-dimycolate) from nine species of mycobacteria by MALDI-TOF mass spectrometry. Microbiology 151 : 3403 3416. (Pubitemid 41488922)
17. Fujita Y, Okamoto Y, Uenishi Y, Sunagawa M, Uchiyama T Yano I (2007) Molecular and supra-molecular structure related differences in toxicity and granulomatogenic activity of mycobacterial cord factor in mice. Microb Pathogenesis 43 : 10 21. (Pubitemid 46678643)
18. Geisel RE, Sakamoto K, Russell DG Rhoades ER (2005) In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette-Guérin is due principally to trehalose mycolates. J Immunol 174 : 5007 5015.
19. Honda I, Seki M, Ikeda N, Yamamoto S, Yano I, Koyama A Toida I (2006) Identification of two subpopulations of bacillus Calmette-Guérin (BCG) Tokyo172 substrain with different RD16 regions. Vaccine 24 : 4969 4974. (Pubitemid 44218934)
20. Indrigo J, Hunter RL Jr. Actor JK (2003) Cord factor trehalose 6,6′-dimycolate (TDM) mediates trafficking events during mycobacterial infection of murine macrophages. Microbiology 149 : 2049 2059. (Pubitemid 37038411)
21. Jagannath C, Actor JK Hunter RL Jr. (1998) Induction of nitric oxide in human monocytes and monocyte cell lines by Mycobacterium tuberculosis. Nitric Oxide 2 : 174 186. (Pubitemid 28399893)
22. Keller PM, Böttger EC Sander P (2008) Tuberculosis vaccine strain Mycobacterium bovis BCG Russia is a natural recA mutant. BMC Microbiol 8 : 120.
23. Kubin M, Chow JM Trinchieri G (1994) Differential regulation of interleukin-12 (IL-12), tumor necrosis factor α, and IL-1β production in human myeloid leukemia cell lines and peripheral blood mononuclear cells. Blood 83 : 1847 1855. (Pubitemid 24107908)
24. Lucey DR, Clerici M Shearer GM (1996) Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev 9 : 532 562. (Pubitemid 26366537)
25. Matsumura T, Degawa T, Takii T, Hayashi H, Okamoto T, Inoue J Onozaki K (2003) TRAF6-NF-κB pathway is essential for interleukin-1-induced TLR2 expression and its functional response to TLR2 ligand in murine hepatocytes. Immunology 109 : 127 136. (Pubitemid 36577983)
26. Roy S, Sharma S, Sharma M, Aggarwal R Bose M (2004) Induction of nitric oxide release from the human alveolar epithelial cell line A549: an in vitro correlate of innate immune response to Mycobacterium tuberculosis. Immunology 112 : 471 480. (Pubitemid 38859526)
27. Ryll R, Kumazawa Y Yano I (2001) Immunological properties of trehalose dimycolate (cord factor) and other mycolic acid-containing glycolipids. Microbiol Immunol 45 : 801 811. (Pubitemid 34019545)
28. Suzuki K, Fukutomi Y, Matsuoka M, Torii K, Hayashi H, Takii T, Oomoto Y Onozaki K (1993) Differential production of interleukin 1 (IL-1), IL-6, tumor necrosis factor, and IL-1 receptor antagonist by human monocytes stimulated with Mycobacterium leprae and M. bovis BCG. Int J Leprosy 61 : 609 618. (Pubitemid 24129420)
29. Takii T, Abe C, Tamura A, Ramayah S, Belisle JT, Brennan PJ Onozaki K (2001) Interleukin-1 or tumor necrosis factor-α augmented the cytotoxic effect of mycobacteria on human fibroblasts: application to evaluation of pathogenesis of clinical isolates of Mycobacterium tuberculosis and M. avium complex. J Interf Cytok Res 21 : 187 196. (Pubitemid 32680905)
30. Taylor BS, de Vera ME, Ganster RW, Wang Q, Shapiro RA, Morris SM Jr., Billiar TR Geller DA (1998) Multiple NF-κB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J Biol Chem 273 : 15148 15156. (Pubitemid 28272813)
31. Thoma-Uszynski S, Stenger S, Takeuchi O et al 2001) Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 291 : 1544 1547. (Pubitemid 32179220)
32. Van der Laan LJ, Döpp EA, Haworth R, Pikkarainen T, Kangas M, Elomaa O, Dijkstra CD, Gordon S, Tryggvason K Kraal G (1999) Regulation and functional involvement of macrophage scavenger receptor MARCO in clearance of bacteria in vivo. J Immunol 162 : 939 947. (Pubitemid 29035419)
33. Volpe E, Cappelli G, Grassi M, Martino A, Serafino A, Colizzi V, Sanarico N Mariani F (2006) Gene expression profiling of human macrophages at late time of infection with Mycobacterium tuberculosis. Immunology 118 : 449 460. (Pubitemid 44079565)
34. Weinberg JB, Misukonis MA, Shami PJ et al 1995) Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 86 : 1184 1195.
35. WHO Global Tuberculosis Programme and Global Programme on Vaccines (1995) Statement on BCG revaccination for the prevention of tuberculosis. WHO Wkly Epidem Rec 70 : 229 231.
36. WHO Report (1999) Issues Relation to the Use of BCG in Immunization Programmes. World Health Organization, Geneva.
37. WHO Report (2005) WHO Discussion on the Improvement of the Quality Control of BCG Vaccine. Pasteur Institute, Paris, France.
38. Wickremasinghe MI, Thomas LH Friedland JS (1999) Pulmonary epithelial cells are a source of IL-8 in the response to Mycobacterium tuberculosis: essential role of IL-1 from infected monocytes in a NF-κB-dependent network. J Immunol 163 : 3936 3947. (Pubitemid 29450922)
39. Yang J, Kawamura I, Zhu H Mitsuyama M (1995) Involvement of natural killer cells in nitric oxide production by spleen cells after stimulation with Mycobacterium bovis BCG. Study of the mechanism of the different abilities of viable and killed BCG. J Immunol 155 : 5728 5735.
40. Yarkoni E Bekierkunst A (1976) Nonspecific resistance against infection with Salmonella typhi and Salmonella typhimurium induced in mice by cord factor (trehalose-6,6′-dimycolate) and its analogues. Infect Immun 14 : 1375 1377.